Member News

Catalyst is proud to announce the successful sale last summer of 90% of the Catalyst MENA Clean Energy Fund (CMCF) portfolio. The sale of 4 utility scale solar PV projects located in Jordan and Egypt were sold as a portfolio to an international strategic buyer, resulting in top quartile returns. Catalyst’s investors are primarily EU Governments. Catalyst has made a significant impact on the renewable energy landscape by developing some of the MENA region’s first utility scale solar PV projects, across Jordan and Egypt.

BII’s investment led to the implementation of green building practices across all TVS ILP’s warehouses in India. BII remains as significant minority stakeholder to support TVS ILP’s growth plans

Africa Finance Corporation (AFC), the continent’s leading infrastructure solutions provider, has exited its 35% equity investment in Atlantic Terminal Services Limited (ATSL), the concessionaire for the expansion of Ghana’s Takoradi Port, to the global ports and container terminals operator Yilport Holding. This is testament to the Corporation’s ability to attract international 3rd party capital and exit strategic infrastructure assets built by derisking through AFC’s unique project development and construction offering.

Accra, Ghana - Oasis Capital Ghana, an SME growth equity investor in West Africa, is delighted to announce the successful exit of its holdings in Legacy Girls College (LGC), a leading educational institution based in Ghana catering exclusively to female students. This achievement marks a significant milestone as it represents the first complete exit from the Oasis Africa Fund I.

Casablanca, July 24, 2023 – AfricInvest is pleased to announce its exit from Promamec, a Moroccan pioneer in the production and distribution of medical devices for the public and private sectors. Founded in 2000, the company has steadily grown to become one of the Moroccan leaders in the provision of a diverse range of medical devices. Thanks to its innovative strategy and dedicated teams, Promamec engaged in exclusive partnerships with several internationally renowned brands allowing the company to cover a wide spectrum of medical specialties.

CSCS is a financial market infrastructure platform and is the sole licensee for the central depository and settlement of transactions on the Nigerian Exchange Limited ("NGX"), amongst others.

Acquisition to enable creation of a fully integrated, enterprise-wide capability to discover, design and develop next-generation immunotherapies at scale by leveraging artificial intelligence and machine learning technologies across BioNTech’s therapeutic platforms and operations Builds on multi-year strategic collaboration between BioNTech and InstaDeep which included the formation of an AI Innovation Lab in 2020 and completion of dozens of joint projects  Acquisition expected to add approximately 240 highly skilled professionals and a global network of research partners in the fields of artificial intelligence, machine learning and data science based in the world’s leading global technology hubs  BioNTech to pay an upfront consideration of approximately £362 million in cash and BioNTech shares, to acquire 100% of remaining InstaDeep shares following BioNTech’s Series B investment in 2022 InstaDeep to operate globally from London headquarters as a BioNTech company post-closing, which is expected in the first half of 2023, subject to regulatory approval